Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?

Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?

Tacrolimus (FK506) is the most widely used anti-rejection drug in kidney transplantation, especially its extended release Tacrolimus formulation (ER-Tac, Advagraf), which is used when target blood levels can be difficult to reach in high metabolizer patients. In this retrospective monocentric study,...

Full description

Bibliographic Details
Main Authors: Paolo Carta, Federica Curci, Leonardo Caroti, Larti Aida, Lorenzo Di Maria, Lino Cirami
Format: Article
Language:English
Published: Codon Publications 2020-05-01
Series:Journal of Renal and Hepatic Disorders
Subjects:
kidney transplantation; extended-dose-release Tacrolimus; melt-dose Tacrolimus; renal function; tremors; high metabolizer recipients
Online Access:https://jrenhep.com/index.php/jrenhep/article/view/68

Similar Items

Similar Items